Protean BioDiagnostics
Test Menu Screening Menu Test Ordering Information Test Requisition Forms
Cancer Test Menu Protean MAPS® Genetic Testing: Risk MAPS™
Cancer Consultations Cancer Test Information Risk MAPS™ Hereditary Testing
Research Services Collaborative Research Opportunities Research Publications
Blog Press Cancer Podcast
About Us Operating Hours The Team Pathologists Careers Contact
Test Menu Test Menu Screening Menu Test Ordering Information Test Requisition Forms Physicians + Hospitals Cancer Test Menu Protean MAPS® Genetic Testing: Risk MAPS™ Patients Cancer Consultations Cancer Test Information Risk MAPS™ Hereditary Testing CRO Research Services Collaborative Research Opportunities Research Publications News Blog Press Cancer Podcast About About Us Operating Hours The Team Pathologists Careers Contact
Protean BioDiagnostics
Protean Presents Research Utilizing NGS at AMP 2023
Protean Presents Research Utilizing NGS at AMP 2023

In this study, we analyzed 80 pan-cancer cases that underwent comprehensive genomic testing and compared the auto-classified variant tiers among four globally-available software solutions for variant interpretation from Roche, SOPHiA GENETICS, QIAGEN, and Genoox.

Read More
Anthony MaglioccoMarch 1, 2024
Dr. Magliocco Featured in Pathology Spotlight
Dr. Magliocco Featured in Pathology Spotlight

Anthony Magliocco, CEO of Protean has been featured in the December Member Spotlight for the Florida Society of Pathologists.

Read More
Anthony MaglioccoJanuary 9, 2024
Protean Presents Multiple Abstracts at AMP
Protean Presents Multiple Abstracts at AMP

Protean congratulates Roy Khalife and Saar Peles on their research, presented at AMP 2023.

Read More
Anthony MaglioccoNovember 30, 2023
Dr. Magliocco to Present at Future of Cancer Care
Dr. Magliocco to Present at Future of Cancer Care

Dr. Magliocco will be speaking at Future of Cancer Care on November 9th!

Read More
Anthony MaglioccoNovember 6, 2023
Announcing Aventa FusionPlus
Announcing Aventa FusionPlus

Protean has partnered with Aventa to bring the Aventa FusionPlus test to patients

Read More
Anthony MaglioccoOctober 4, 2023
Announcing Protean's Partnership with Travera
Announcing Protean's Partnership with Travera

Protean’s new partnership with Travera will bring expanded treatment options to advanced carcinoma patients and their physicians

Read More
Anthony MaglioccoAugust 22, 2023
Newer Older
 
 

Physicians and Hospitals | Patients | Research Partners
Careers | Blog | Press | Contact | Research Publications
 

Notice of Privacy Practices